Situation: The public health nurse of a Rural Health Unit (RHU) holds a Philippine Package of Essential NCD Interventions (PhilPEN) screening day for noncommunicable diseases (NCDs) at the barangay hall. Barangay health workers (BHWs) help register the residents. A 35-year-old woman with obesity says her mother has diabetes. She has no excessive thirst, frequent urination, or weight loss. She can return fasting the next morning. Which test should the nurse arrange FIRST to screen her for diabetes?

Obesity and a family history of diabetes are indications for glucose testing at a PhilPEN screening. Fasting plasma (or capillary) glucose is the usual first community screening test, and a result of 126 mg/dL (7.0 mmol/L) or more is confirmed before diagnosis. Because she can return fasting, the preferred fasting test is arranged rather than a random glucose.

Clinical context
A 35-year-old woman with obesity and a first-degree family history of diabetes is asymptomatic but has clear risk factors for type 2 diabetes. In a PhilPEN community screening setting, the goal is early detection using a practical, low-cost, and reasonably accurate test. Because she can return fasting the next morning, the nurse should arrange a fasting plasma or capillary blood glucose as the first screening test.

Why fasting glucose is the correct first step
PhilPEN follows a stepped screening approach that begins with risk assessment, then moves to blood glucose testing in people identified as high risk. Obesity and a positive family history place this woman in the high-risk category, so glucose testing is indicated. The preferred initial test is a fasting sample because it is standardized, inexpensive, and widely available in primary care and rural health settings. A fasting plasma glucose of 126 mg/dL (7.0 mmol/L) or higher is the diagnostic threshold that triggers confirmation and referral.

Fasting glucose is preferred over random glucose when the person can safely return after an overnight fast, because fasting values are more reproducible and directly align with diagnostic criteria. A random capillary glucose at the station would be convenient but is less reliable for initial screening in an asymptomatic person, since it is influenced by recent food intake and lacks a clear single-visit diagnostic cutoff.

Why the other options are not the first choice
Urine glucose by dipstick is not appropriate for screening. Glucose appears in urine only when the blood glucose exceeds the renal threshold, so it misses early or mild hyperglycemia and produces false negatives in many people with prediabetes or early type 2 diabetes.

Glycated hemoglobin (HbA1c) is a valid diagnostic tool, but it is not the usual first community screening test in the PhilPEN context. HbA1c requires laboratory infrastructure, is more costly, and can be affected by conditions that alter red blood cell turnover, such as anemia or hemoglobinopathies. In resource-limited rural health units, fasting glucose remains the more practical initial test.

Random capillary glucose is useful for quick point-of-care assessment, especially in symptomatic individuals, but this woman has no classic symptoms such as polyuria, polydipsia, or unexplained weight loss. Key point! In an asymptomatic person with risk factors, a fasting sample is more informative than a random sample because it can be compared directly with the diagnostic threshold.

How the evidence supports this approach
A population-based Australian screening study evaluated a stepped protocol very similar to PhilPEN: assess risk status first, then measure fasting plasma glucose in high-risk individuals, and proceed to further testing based on the fasting result. That protocol achieved a sensitivity of 79.9% and specificity of 79.9% for detecting undiagnosed type 2 diabetes and impaired glucose metabolism, demonstrating that fasting glucose is a reasonable first-line screening tool in community settings ^[3].

A meta-analysis comparing HbA1c with fasting plasma glucose and oral glucose tolerance testing noted that HbA1c was officially recommended as a screening tool with cutoffs of 6.5% for diabetes and 5.7–6.4% for prediabetes, but the implications of using HbA1c instead of fasting glucose remain debated ^[2]. This supports the idea that HbA1c is not automatically the first test in every setting, especially where fasting glucose is more feasible.

A more recent study suggested that 1-hour plasma glucose may outperform fasting glucose, 2-hour glucose, and HbA1c for diagnosing type 2 diabetes ^[4]. However, this is an emerging research area and does not change the current PhilPEN-based practice of using fasting glucose as the initial community screening test. Watch out! Do not confuse newer diagnostic research proposals with the established first-step screening test in a rural health unit.

The decision hinges on feasibility and diagnostic alignment: when a person can return fasting, arrange the fasting glucose test rather than a random or urine-based test. If the fasting result is 126 mg/dL (7.0 mmol/L) or higher, the next step is confirmation and referral for further evaluation, not immediate diagnosis based on a single community screening value.